Mimedx Group, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$5.2Mgeneral payments (2019-2025)
$43Kresearch payments (2019-2025)
9,518clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2024 $2.5M
2025 $2.7M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Obstetrics & Gynecology $1.4M
Orthopaedic Surgery $563K
Internal Medicine $479K
Foot & Ankle Surgery $348K
Blood Banking & Transfusion Medicine $270K
Vascular Surgery $212K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Cato Laurencin Charlottesville, VA Orthopaedic Surgery $547,713.00
Phyllis Gardner Stanford, CA Internal Medicine $319,668.75
Michael Bauer Castle Rock, CO Blood Banking & Transfusion Medicine $270,320.00
Megan Oltmann Solon, OH Primary Podiatric Medicine $162,504.98
Scott Boynton Portland, OR Foot & Ankle Surgery $118,043.51
David Shulkin Morristown, NJ Internal Medicine $105,000.00
Bidhan Das Sugar Land, TX Colon & Rectal Surgery $82,729.85
Nicolas Mouawad West Branch, MI Vascular Surgery $82,597.91
Naz Wahab Las Vegas, NV Family Medicine $68,532.76
Brett Cascio Lake Charles, LA Sports Medicine (Orthopaedic Surgery) $63,692.55

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.